Advertisement
Home Tags Parkinson’s

Tag: Parkinson’s

Patients with degenerative brain diseases die about two years earlier compared with people who don't have these conditions

Life Expectancy Slighter Shorter With Parkinson’s, Dementia

0
Two-year difference seen between people with degenerative brain diseases and their healthy peers
Overall vagotomy is not associated with the risk of Parkinson's disease

Overall Vagotomy Not Linked to Risk of Parkinson’s Disease

0
But there is a trend toward lower risk of Parkinson's for patients with truncal vagotomy
Apomorphine may help patients with advanced Parkinson's disease when levodopa stops working

AAN: Apomorphine May Shorten ‘Off’ Time for Parkinson’s Patients

0
Study finds apomorphine cuts the time until levodopa kicks in for those with advanced disease
Cerebral hypoperfusion contributes to dizziness in patients with Parkinson's disease

Dizziness in Parkinson’s May Be Due to Cerebral Hypoperfusion

0
Transcranial Doppler during head-up tilting useful for evaluating dizziness
Individuals with hepatitis B and hepatitis C have increased rates of subsequent Parkinson's disease

Hepatitis B, C Linked to Higher Subsequent Rates of Parkinson’s

0
Increased rates of subsequent Parkinson's for those with hepatitis B, C, but not autoimmune hepatitis
For patients with Parkinson's disease

Regular Exercise Slows Decline Even in Advanced Parkinson’s Dz

0
Slower declines in health-related quality of life, mobility for increasing exercise by 30 minutes/week
Xadago (safinamide) tablets have been approved by the U.S. Food and Drug Administration as an add-on drug to treat Parkinson's patients who take levodopa or carbidopa but experience "off" episodes.

FDA Approves New Parkinson’s Add-On Drug Xadago

0
To help prevent 'off' episodes among users of levodopa/carbidopa
Measuring blood neurofilament light chain levels may help distinguish Parkinson's disease from atypical parkinsonian disorders

Diagnostic Potential for Blood-Based NfL in Parkinson’s Disease

0
Blood neurofilament light chain levels may prove useful in both primary care and specialized clinics
Cognitive co-activation is associated with a significantly smaller levodopa effect on resting tremor in Parkinson's disease

Cognitive Stress Reduces Levodopa Effect in Parkinson’s

0
Levodopa effect significantly smaller during cognitive co-activation than during rest
For patients with Parkinson's disease receiving levodopa therapy and experiencing end-of-dose motor fluctuations

Opicapone As Levodopa Adjunct Cuts Motor Fluctuations in PD

0
In Parkinson's disease, 50-mg/day opicapone linked to significant reduction in mean daily off-time